Evidence map›Paper›PMID 42766626›Full record

ArticlePloS one2026

Low contrast visual acuity in healthy adults: Impact on non-pathologic myopia.

Toshio Narimatsu, Noriko Onozato, Haruna Togawa, Shigeto Shimmura, Yoko Ozawa

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Toshio NarimatsuDepartment of Clinical Regenerative Medicine, Fujita Health University School of Medicine, Ota, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2844-1046
Noriko OnozatoFujita Medical Innovation Center Tokyo, Ota, Tokyo, Japan.
Haruna TogawaFujita Medical Innovation Center Tokyo, Ota, Tokyo, Japan.
Shigeto ShimmuraDepartment of Clinical Regenerative Medicine, Fujita Health University School of Medicine, Ota, Tokyo, Japan.
Yoko OzawaDepartment of Clinical Regenerative Medicine, Fujita Health University School of Medicine, Ota, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4797-5705

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increase in myopia is a social issue worldwide. However, whether non-pathologic myopia with normal best-corrected visual acuity (BCVA) exhibits differences in visual ability is not well-documented. Data of 43 healthy eyes in 43 participants (52.8 ± 6.07 years) including 13 (30.2%) males who underwent eye medical checkups at Fujita Medical Innovation Center, Tokyo were retrospectively analyzed. Eyes with general BCVA 0 in logMAR or better and without histories of ocular diseases and surgeries were included. Mean low-contrast visual acuity (LCVA) measured using grey-scale optotypes with best correction was 0.17 ± 0.13 (range, -0.079-0.53; median, 0.15). LCVA was correlated with age (r = 0.2634, 95% confidence interval [CI] -0.040-0.522, P = 0.039). Eyes with LCVA better than 0.15 was associated with uncorrected visual acuity (OR, 43.425; 95%CI, 3.729-1250.027; P = 0.010), subjective spherical equivalent (OR, 1.761; 95%CI, 1.255-2.776; P = 0.004), subjective spherical power (OR, 1.616; 95%CI, 1.186-2.433; P = 0.008), and axial length (OR, 0.550; 95%CI, 0.293-0.951; P = 0.032) after adjusted for age and sex. Mean LCVA of less myopic eyes with spherical equivalent > -3.0 diopters was 0.12 ± 0.10 (median, 0.10), and that of more myopic eyes was 0.23 ± 0.14 (median, 0.22) (P < 0.001). Non-pathological myopic eyes exhibited worse LCVA under best correction and had a risk of worse visual ability.

Indexed as

MyopiaVisual AcuityAdultFemaleHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID42766626
PMCPMC13592576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.